Cancer patients get extended access to promising drugs in safety study

NCT ID NCT06174987

Recruiting now Disease control Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

Summary

This study allows cancer patients who are benefiting from certain Daiichi Sankyo or AstraZeneca drugs to continue receiving those treatments while researchers monitor long-term safety. The study is for people with advanced or metastatic cancer who participated in previous company-sponsored trials and haven't shown disease progression. Researchers will track side effects and safety issues that occur during extended treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

A.C. Camargo Cancer Center
NOT_YET_RECRUITING

São Paulo, Brazil
Asan Medical Center
RECRUITING

Seoul, 05505, South Korea
Complejo Hospitalario Universitario A Coruña
RECRUITING

A Coruña, 15006, Spain
Duke University - Trent Center
RECRUITING

Durham, North Carolina, 27710, United States
Flinders Medical Center
ACTIVE_NOT_RECRUITING

Bedford Park, 5042, Australia
Grand Hôpital de Charleroi
RECRUITING

Charleroi, 6000, Belgium
Hospital Ruber Internacional
WITHDRAWN

Madrid, 28034, Spain
Hospital Universitari Dexeus
NOT_YET_RECRUITING

Distrito de Les Corts, 08028, Spain
Hospital Universitari Vall d'Hebron
RECRUITING

Barcelona, 08035, Spain
IBCC Nucleo de Pequisa e Ensino
NOT_YET_RECRUITING

São Paulo, Brazil
ICO l'Hospitalet - Hospital Duran i Reynals
RECRUITING

L'Hospitalet de Llobregat, 08908, Spain
Institut Gustave Roussy
RECRUITING

Villejuif, 94805, France
Instituto Aericas
NOT_YET_RECRUITING

Rio de Janeiro, Brazil
Istituto Nazionale Tumori Fondazione G. Pascale
WITHDRAWN

Naples, 80131, Italy
Kyungpook National University Chilgok Hospital
RECRUITING

Daegu, 41404, South Korea
Miami Cancer Institute
RECRUITING

Miami, Florida, 33176, United States
Monash Medical Center
WITHDRAWN

Melbourne, 3168, Australia
National Cancer Center
RECRUITING

Gyeonggi-do, 10408, South Korea
National Cancer Center Hospital
RECRUITING

Chūō, 104-0045, Japan
National Cheng Kung University Hospital
WITHDRAWN

Tainan, 704, Taiwan
National Taiwan University Hospital
WITHDRAWN

Taipei, 10002, Taiwan
Ospedale San Raffaele
RECRUITING

Milan, 20132, Italy
Rabin Medical Center
ACTIVE_NOT_RECRUITING

Petah Tikva, Israel
Royal Surrey County Hospital
WITHDRAWN

Guildford, GU2 7XX, United Kingdom
Samsung Medical Center
RECRUITING

Seoul, 06351, South Korea
Seoul National University Bundang Hospital
WITHDRAWN

Gyeonggi-do, 13620, South Korea
Seoul National University Hospital
RECRUITING

Jongno-gu, 03080, South Korea
Severance Hospital, Yonsei University
RECRUITING

Seoul, 03722, South Korea

Conditions

Explore the condition pages connected to this study.

ADVANCED CANCER METASTATIC CANCER